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Haemodialysis (HD) treatment is supposed to correct months in 61 patients (21 females; mean age 59.8 the fluid overload by achievement of dry-weight, a sort years; 20% diabetic), treated with cellulosic membranes of 'Holy Grail' in the HD practice. Dry weight has for 8 h, 3 times a week. been previously defined [2] . In our experience, it is the Results. The post-dialysis body-weight decreased post-dialysis body-weight that allows the pre-dialysis between the onset of HD and month 2 (M2) blood pressure to remain normal (i.e. ∏130/80 mmHg (−4.40±0.52%). Then it went up, reaching or mean arterial pressure (MAP) ∏96 mmHg), despite −1.56±0.96% at M6, +0.3±1.27% at M12, the interdialytic weight gain and without the need of +1.27±1.38% at M18 and +1.64±1.33% at M24.
antihypertensive drugs. Also, at dry weight, the patient The post-dialysis body-weight increased by 6% between has no clinical signs or symptoms of fluid overload or M2 and M24. The mean arterial pressure (MAP) hypovolaemia. decreased from 111.3±2.5 mmHg at M0 to 94.4±1.7
Moreover, improvement of nutritional status by the at M6, and then remained stable after M6. Between onset of the HD treatment has been an early observa-M2 and M6 the post-dialysis body-weight increased, tion [3] . Then, in the first months of the HD treatment, whereas the predialysis MAP continued to decline. The the evolution of the body-weight is the net result of incidence of hypotension episodes was maximal during two opposing processes, i.e. control of the extracellular the first 4 months of HD treatment.
fluid volume to reverse hypertension on the one hand Conclusions. After the second month of dialysis treatand increase in 'dry mass' as a result of anabolism ment, the simultaneous increase of post-dialysis bodyinduced by HD treatment on the other. weight and decrease of pre-dialysis MAP are related
In this study we report the changes in post-dialysis to the effects of two processes, i.e. increased weight as body-weight and the blood pressure during the 24 the result of anabolism induced by the HD treatment months following onset of the HD treatment in patients on the one hand and normalization of blood pressure treated with HD sessions of long duration. by fluid removal on the other. Continuous clinical assessment of the patient is necessary to provide adequate prescription of post-dialysis body-weight.
Subjects and methods
During the first months of HD treatment, the nephrologist, like Janus, is a double-faced gatekeeper: he must Patients be willing to decrease post-dialysis weight to achieve 'dry weight' and to normalize blood pressure, but he peritoneal dialysis programme, n=4; malignant disease, Results n=6; hospitalization >4 months in a row, n=1; follow-up less than 2 years (kidney transplantation, n=8; transfer to The patients characteristics are reported in Table 1 . another unit, n=8; transfer to self or home HD programme, The 61 studied patients were aged 59.8 years and 15/61 n=12; death, n=8). Sixty-one patients remained available (24.6%) were over 70 at the beginning of the HD for the study.
treatment. The average pre-dialysis body weight at the first HD treatment was 65.3 kg (range 43.3-108.7).
Post-dialysis body-weight evolution
The cause of ESRD were nephrosclerosis (23%), diabetes (20%), chronic glomerulonephritis (18%), After each HD treatment, according to interdialytic symp-unknown (18%), uropathy (10%), polycystic kidney toms, physical examination, pre-and postdialysis blood disease (6.5%), and miscellaneous (4.5%).
pressure data and perdialytic side-effects such as cramps and Dialysis parameters are summarized in Table 2 . All hypotension reported on the dialysis flowsheet, the nephrolo-the patients began dialysis treatment on a basis of 3×8 gist determines the body-weight to be achieved at the end of h/week. Eight patients included in the study were next HD treatment. Usually, in the first weeks of the HD changed to 3×5 h/week after 10.1±2.9 months. All treatment, the prescribed post-dialysis weight is gradually decreased by steps of 200-500 g per session up to normaliza-patients were treated with a reused cellulosic membrane tion of blood pressure, and according to perdialytic and (cuprophan 91.4%, or hemophan 8.6%). The dialysate interdialytic tolerance. During the same period the antihyper-buffer was acetate (35 mmol/l ) in 79% and bicarbonate tensive medications are progressively tapered down and (35 mmol/l ) in 21% of the patients. The mean sodium stopped. The body-weight balance (difference between pre-content of dialysate was stable throughout the dialysis scribed and achieved post-dialysis body-weight) is automatic-session and was 137 mmol/l in acetate dialysate and ally displayed on the dialysis flowsheet and taken into 140 mmol/l in bicarbonate dialysate. The dietary account for the ultrafiltration volume at each HD session. sodium counselling was 4 g/day. The average of the All these data are computerized (Alis-LAP, Metz, France), monthly determined Daugirdas index (second generaallowing for an easy extraction of data for analysis. tion) and normalized proteic catabolic rate were
The post-dialysis body-weight was compared over the 24-month period to the pre-dialysis body weight at the first HD respectively 1.92±0.06 and 1.18±0.03 g/kg/day for treatment. This variation of the post-dialysis body-weight the 24-month period. The average predialysis was calculated according to the following formula: serum bicarbonate over the 24-month period was 19.7±3.7 mmol/l ( Table 1) .
monthly average of post-dialysis body-weight predialysis body-weight at the first HD treatment ×100
A marked decrease of the post-dialysis body weight occurred during the first 2 months of the treatment, at Post-dialysis body-weight data have been calculated for M2 reaching −4.37% of the predialysis body weight the months 2, 6, 12, 18, and 24, referred to as M2, M6, M12, at the first HD treatment (Figure 1 ). Then the post-M18 and M24. Side-effects such as muscular cramps and hypotension epis- (0.74-4.08) odes are collected from the flowsheets by the nephrologist and computerized at the end of each haemodialysis session. aAverage over 24 months of the monthly determination of Daugirdas Hypotension is defined by a symptomatic drop of blood index and nPCR. pressure, requiring from the staff saline infusion or a stop of the ultrafiltration programme. dialysis body-weight increased up to +1.64±1.33% at periodical adjustment of post-dialysis body-weight until blood pressure is normalized. The difference of M24. Between M2 and M24, the increase of the bodyweight reached 6%. The post-dialysis body-weight vari-pre-and post-dialysis MAP did not vary significantly over the studied period and averaged 14.2±1.2 mmHg. ations were significantly different throughout the two periods (M0-M6, P=0.00000; M6-M24, P=0.00086). Whereas the cramp incidence did not vary along the study period ( Figure 3 ), the incidence of hypotension The evolution of the blood pressure is reported in Figure 1 . The initial MAP was 111.8±19.9 mmHg. At episodes was maximum during the first 4 months of treatment, reaching 20.3% of incidence (Figure 3) , and that stage, 85% of the patients were prescribed antihypertensive drugs. At M6, the predialysis MAP was then stabilized under 10% after 1 year of treatment.
The proportion of patients presenting with sympto-94.0±10.6 mmHg and only four patients needed antihypertensive drugs. Between the onset of HD treatment matic hypotension episodes in more than 10% of HD sessions was 39.6% at M1, 36.2% at M6, 29.8% at and M6, the predialysis MAP decreased significantly (P<0.00001). Then it stabilized, and predialysis MAP M12 and 23% at M24. In these patients, the distribution of diabetic patients was stable over the whole data were not different between M6 and M24 according to GLM ANOVA. The average interdialytic weight period. gain was stable over the 24-month period (2.03±0.9 kg at M2, 2.19±0.99 at M6, 2.06±1.07 at M12, Discussion 2.11±0.94 at M18 and 2.03±0.97 at M24), but was lower during M1 (1.44±0.66 kg).
These data document the peculiar evolution of postThe evolution of the weight balance is reported in dialysis body-weight after the onset of the HD treat- Figure 2 . The difference between prescribed and ment. Initially, body-weight decreased by the efforts achieved post-dialysis body-weight was maximum in made to achieve dry weight. The magnitude of the the first months of treatment, corresponding to the decrease was −4.4% at M2, which represents an average loss of 2.9 kg in 2 months. The evolution of the pre-dialysis MAP during this initial period parallels the removal of fluid. Fluid withdrawal is rendered easy by the slow ultrafiltration rate provided by the long dialysis method. This is the key point in the effort to achieve 'dry weight'. Lengthening the HD session time reduces the incidence of hypotensive episodes [5] . However, in the first months of treatment, a higher incidence of hypotension episodes were recorded in our patients, reflecting the effort to achieve 'dry weight'. It may be the price to pay in some patients if one is determined to reach the dry weight and to Fig. 2 . Monthly differences between the prescribed and achieved normalize blood pressure. It is also possible that the post-dialysis body-weight (kg). A difference >0 means that the use of acetate as buffer may favour hypotensive events achieved post-dialysis body-weight is higher than the prescribed post-dialysis body-weight. in some patients during this phase. Between M2 and M6, pre-dialysis MAP continued with biocompatible membranes. The large 'dose' of dialysis delivered may explain why HD treatment to decrease until M6 when it stabilized. In contrast, the post-dialysis body-weight increased. This period induced a remarkable positive effect on post-dialysis body-weight. Chauveau et al. [8] recently found a corresponds to a phase of overlap of two opposing influences: HD treatment increases 'dry weight' by significant linear and positive relationship between Kt/V urea assessed by urea monitoring, and daily inducing anabolism [4, 6 ] while blood pressure is normalized as a result of fluid removal. During this period, protein intake assessed by a 7-day food record.
In conclusion, in our experience, 'dry weight' must the nephrologist is, like Janus, a double-faced gatekeeper of post-dialysis body-weight. One face is the be viewed as a dynamic concept during the initial months of HD treatment. Further studies using more effort to reach the dry weight by decreasing the postdialysis body-weight until normalization of the blood sophisticated methods to assess nutritional and fluid status are necessary to more clearly understand the pressure has been achieved (MAP=96 mmHg). The risk is excessive fluid withdrawal that will lead to mechanism underlying the changes in 'dry weight'. episodes of hypotension during HD sessions and symp-
